New insider activity at Cencora ( (COR) ) has taken place on May 17, 2025.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Director Lon Greenberg has recently executed a significant transaction involving Cencora stock, selling 3,000 shares for a total value of $837,150.
Recent Updates on COR stock
Cencora, Inc. recently reported its fiscal 2025 second-quarter results, highlighting a 10.3% year-over-year revenue growth to $75.5 billion and a significant increase in GAAP diluted EPS to $3.68. This strong performance was primarily driven by the U.S. Healthcare Solutions segment, which saw an 11% revenue increase due to strong utilization trends and specialty product growth. The company’s effective cost management and strategic investments, including the acquisition of Retina Consultants of America, further bolstered its financial results. However, the International Healthcare Solutions segment faced challenges due to market softness, leading to a slight revenue increase but a decrease in operating income. Despite these challenges, Cencora raised its full-year guidance for adjusted operating income and EPS, reflecting confidence in its financial resilience and strategic growth initiatives. Increased interest expenses due to financing for acquisitions slightly offset these positive outcomes.
Spark’s Take on COR Stock
According to Spark, TipRanks’ AI Analyst, COR is a Outperform.
Cencora is performing strongly with robust revenue growth, operational efficiency, and effective cost management. The high leverage is a notable risk, but the company’s strategic focus on expanding its specialty medication offerings and raising guidance reflects confidence in future performance. The technical analysis and valuation suggest caution, as the stock may be experiencing consolidation, and the high P/E ratio points to potential overvaluation.
To see Spark’s full report on COR stock, click here.
More about Cencora
YTD Price Performance: 27.57%
Average Trading Volume: 1,878,468
Technical Sentiment Signal: Buy
Current Market Cap: $54.11B